scholarly article | Q13442814 |
P50 | author | Nathan Paul Wiederhold | Q42104169 |
John R. Graybill | Q109648584 | ||
P2093 | author name string | R Bocanegra | |
T F Patterson | |||
L K Najvar | |||
C Lambros | |||
N Najarian | |||
P433 | issue | 6 | |
P921 | main subject | candidiasis | Q273510 |
Aminocandin | Q4746450 | ||
P304 | page(s) | 595-600 | |
P577 | publication date | 2008-04-05 | |
P1433 | published in | Clinical Microbiology and Infection | Q15757285 |
P1476 | title | Therapeutic and prophylactic efficacy of aminocandin (IP960) against disseminated candidiasis in mice | |
P478 | volume | 14 |
Q37918556 | Addressing current medical needs in invasive fungal infection prevention and treatment with new antifungal agents, strategies and formulations |
Q41990022 | Caspofungin dose escalation for invasive candidiasis due to resistant Candida albicans. |
Q37718385 | Echinocandin pharmacodynamics: review and clinical implications. |
Q37358668 | Effect of Antifungal Treatment in a Diet-Based Murine Model of Disseminated Candidiasis Acquired via the Gastrointestinal Tract. |
Q91865119 | Efficacy of humanized single large doses of caspofungin on the lethality and fungal tissue burden in a deeply neutropenic murine model against Candida albicans and Candida dubliniensis |
Q26828993 | Emerging drugs and vaccines for candidemia |
Q37291442 | Evaluation of aminocandin and caspofungin against Candida glabrata including isolates with reduced caspofungin susceptibility |
Q52588345 | Host defense mechanisms in invasive candidiasis originating in the GI tract. |
Q37557700 | Human fungal pathogen Candida albicans in the postgenomic era: an overview. |
Q44855715 | Newer antifungal agents |
Q47410811 | Oral glucan synthase inhibitor SCY-078 is effective in an experimental murine model of invasive candidiasis caused by WT and echinocandin-resistant Candida glabrata |
Q27025299 | Pharmacokinetics and pharmacodynamics of antifungals in children: clinical implications |
Q35105818 | The novel arylamidine T-2307 maintains in vitro and in vivo activity against echinocandin-resistant Candida albicans. |
Search more.